Media Summary: In this episode of Community Corner, Michael This is the recording of a virtual congressional briefing held on August 28, 2025, hosted by the bipartisan Health Care Innovation ... Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, ...

Dr Wang On The Systemic Challenges Behind Car T Access - Detailed Analysis & Overview

In this episode of Community Corner, Michael This is the recording of a virtual congressional briefing held on August 28, 2025, hosted by the bipartisan Health Care Innovation ... Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, ... Richard D. Kim, MD, Moffitt Cancer Center, Tampa, FL, discusses the Manmeet Ahluwalia, MD, MBA, FASCO, Baptist Health Miami Cancer Institute, Kendall, FL, discusses the advancements and ... This was presented at the Fall Scleroderma Patient Education Conference, held on October 18, 2025, hosted by the Scleroderma ...

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, expresses optimism regarding current immunotherapeutic ... Rakefet Sidlik Muskatel, MD, PhD, Schneider Children's Medical Center of Israel, Petah Tikva, Israel, discusses the current ... In this second presentation of a multi-part series, Saad Kenderian, M.B., Ch.B., Hematology, Mayo Clinic, presents on where ... ASGCT advocates for the ability of all patients that qualify for Website: Twitter: Facebook: LinkedIn: ...

Photo Gallery

Dr Wang on the Systemic Challenges Behind CAR T Access
Dr. Wang on Combatting CAR T-Cell Therapy Resistance in MCL
Dr. Wang on CAR T-Cell Therapy Resistance in MCL
Breakthroughs in Cancer Care: Expanding CAR T Access
Dr. Wang on Future Research With CAR T-Cell Therapy in MCL
Challenges for access to CAR T-cell therapy
Challenges faced with the production of universal CAR-T products
The challenges in implementing CAR-T cell therapy for the treatment of solid tumors
Advancements and challenges in CAR-T cell therapy
Dr. Wang on the New CAR T-Cell Therapy in Hematologic Cancers
Can CAR-T Therapy Help Patients With Solid Tumors?
New Advances in Cellular Therapy for Scleroderma: CAR-T and Stem Cells - George Georges, MD
View Detailed Profile
Dr Wang on the Systemic Challenges Behind CAR T Access

Dr Wang on the Systemic Challenges Behind CAR T Access

In this episode of Community Corner, Michael

Dr. Wang on Combatting CAR T-Cell Therapy Resistance in MCL

Dr. Wang on Combatting CAR T-Cell Therapy Resistance in MCL

Michael

Dr. Wang on CAR T-Cell Therapy Resistance in MCL

Dr. Wang on CAR T-Cell Therapy Resistance in MCL

Michael

Breakthroughs in Cancer Care: Expanding CAR T Access

Breakthroughs in Cancer Care: Expanding CAR T Access

This is the recording of a virtual congressional briefing held on August 28, 2025, hosted by the bipartisan Health Care Innovation ...

Dr. Wang on Future Research With CAR T-Cell Therapy in MCL

Dr. Wang on Future Research With CAR T-Cell Therapy in MCL

Michael

Challenges for access to CAR T-cell therapy

Challenges for access to CAR T-cell therapy

Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, held in Budapest, ...

Challenges faced with the production of universal CAR-T products

Challenges faced with the production of universal CAR-T products

In this video, Xinxin

The challenges in implementing CAR-T cell therapy for the treatment of solid tumors

The challenges in implementing CAR-T cell therapy for the treatment of solid tumors

Richard D. Kim, MD, Moffitt Cancer Center, Tampa, FL, discusses the

Advancements and challenges in CAR-T cell therapy

Advancements and challenges in CAR-T cell therapy

Manmeet Ahluwalia, MD, MBA, FASCO, Baptist Health Miami Cancer Institute, Kendall, FL, discusses the advancements and ...

Dr. Wang on the New CAR T-Cell Therapy in Hematologic Cancers

Dr. Wang on the New CAR T-Cell Therapy in Hematologic Cancers

Xiuli

Can CAR-T Therapy Help Patients With Solid Tumors?

Can CAR-T Therapy Help Patients With Solid Tumors?

CAR

New Advances in Cellular Therapy for Scleroderma: CAR-T and Stem Cells - George Georges, MD

New Advances in Cellular Therapy for Scleroderma: CAR-T and Stem Cells - George Georges, MD

This was presented at the Fall Scleroderma Patient Education Conference, held on October 18, 2025, hosted by the Scleroderma ...

Managing toxicities associated with CAR-T therapies

Managing toxicities associated with CAR-T therapies

Michael L.

Overcoming challenges in CAR T-cell therapy for multiple myeloma

Overcoming challenges in CAR T-cell therapy for multiple myeloma

Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, expresses optimism regarding current immunotherapeutic ...

Current challenges affecting the efficacy of CAR T-cell therapy in ALL and how these may be overcome

Current challenges affecting the efficacy of CAR T-cell therapy in ALL and how these may be overcome

Rakefet Sidlik Muskatel, MD, PhD, Schneider Children's Medical Center of Israel, Petah Tikva, Israel, discusses the current ...

Cancer Immunotherapy Workshop 2021 – Engineering Remotely Controllable CAR T Cells

Cancer Immunotherapy Workshop 2021 – Engineering Remotely Controllable CAR T Cells

Featuring: Peter

Understanding CAR T-cell therapy (November 2020)

Understanding CAR T-cell therapy (November 2020)

Understanding

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine

CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine

In this second presentation of a multi-part series, Saad Kenderian, M.B., Ch.B., Hematology, Mayo Clinic, presents on where ...

Access to CAR T-Cell Therapy

Access to CAR T-Cell Therapy

ASGCT advocates for the ability of all patients that qualify for

Dr. Wang on the Safety Profile of KTE-X19 in MCL

Dr. Wang on the Safety Profile of KTE-X19 in MCL

Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: ...